Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-21

FDA Approved: RIFAMPIN — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' original application for rifampin, making a generic rifampin product available through an approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIFAMPIN (RIFAMPIN)

Snippet

ORIG AP for RIFAMPIN (RIFAMPIN)